Correction: Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1+ T lymphocyte niches through a feed-forward loop

Yichao Hua; Gerlanda Vella; Florian Rambow; Elizabeth Allen; Asier Antoranz Martinez; Marie Duhamel; Akira Takeda; Sirpa Jalkanen; Steffie Junius; Ann Smeets; David Nittner; Stefanie Dimmeler; Thomas Hehlgans; Adrian Liston; Francesca Maria Bosisio; Giuseppe Floris; Damya Laoui; Maija Hollmén; Diether Lambrechts; Pascal Merchiers; Jean-Christophe Marine; Susan Schlenner; Gabriele Bergers

doi:10.1016/j.ccell.2022.12.006

Correction: Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1+ T lymphocyte niches through a feed-forward loop

Yichao Hua
, Gerlanda Vella
, Florian Rambow
, Elizabeth Allen
, Asier Antoranz Martinez
, Marie Duhamel
, Akira Takeda
, Sirpa Jalkanen
, Steffie Junius
, Ann Smeets
, David Nittner
, Stefanie Dimmeler
, Thomas Hehlgans
, Adrian Liston
, Francesca Maria Bosisio
, Giuseppe Floris
, Damya Laoui
, Maija Hollmén
, Diether Lambrechts
, Pascal Merchiers

Jean-Christophe Marine, Susan Schlenner, Gabriele Bergers

Research output: Contribution to journal › Article › peer-review

9 Citations (Scopus)

60 Downloads (Pure)

Abstract

(Cancer Cell 40, 1600–1618; December 12, 2022) In this article, the authors demonstrated that antiangiogenic immunotherapies differentiate postcapillary venules into high-endothelial venules (HEVs) that foster permissive TCF1 ⁺ T lymphocyte niches. In the introduction, they mistakenly stated that HEVs express L-Selectin/CD62L, while HEVs express the sulphated and glycosylated ligands for L-Selectin/CD62L. The original article has been corrected online. The authors regret this error and apologize for any confusion this might have caused.

Original language	English
Pages (from-to)	226-226
Number of pages	1
Journal	Cancer Cell
Volume	41
Issue number	1
DOIs	https://doi.org/10.1016/j.ccell.2022.12.006
Publication status	Published - 9 Jan 2023

Bibliographical note

Publisher Copyright:
© 2022 The Author(s)

Copyright:
Copyright 2023 Elsevier B.V., All rights reserved.

Access to Document

10.1016/j.ccell.2022.12.006Licence: CC BY-NC-ND

94997927Final published version, 131 KBLicence: CC BY-NC-ND

Handle.net

Persistent link

Cite this

Hua, Y., Vella, G., Rambow, F., Allen, E., Martinez, A. A., Duhamel, M., Takeda, A., Jalkanen, S., Junius, S., Smeets, A., Nittner, D., Dimmeler, S., Hehlgans, T., Liston, A., Bosisio, F. M., Floris, G., Laoui, D., Hollmén, M., Lambrechts, D., ... Bergers, G. (2023). Correction: Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1+ T lymphocyte niches through a feed-forward loop. Cancer Cell, 41(1), 226-226. https://doi.org/10.1016/j.ccell.2022.12.006

@article{2b12ef09d7a647c392a04b86e7cbbe28,

title = "Correction: Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1+ T lymphocyte niches through a feed-forward loop",

abstract = "(Cancer Cell 40, 1600–1618; December 12, 2022) In this article, the authors demonstrated that antiangiogenic immunotherapies differentiate postcapillary venules into high-endothelial venules (HEVs) that foster permissive TCF1 + T lymphocyte niches. In the introduction, they mistakenly stated that HEVs express L-Selectin/CD62L, while HEVs express the sulphated and glycosylated ligands for L-Selectin/CD62L. The original article has been corrected online. The authors regret this error and apologize for any confusion this might have caused. ",

author = "Yichao Hua and Gerlanda Vella and Florian Rambow and Elizabeth Allen and Martinez, \{Asier Antoranz\} and Marie Duhamel and Akira Takeda and Sirpa Jalkanen and Steffie Junius and Ann Smeets and David Nittner and Stefanie Dimmeler and Thomas Hehlgans and Adrian Liston and Bosisio, \{Francesca Maria\} and Giuseppe Floris and Damya Laoui and Maija Hollm{\'e}n and Diether Lambrechts and Pascal Merchiers and Jean-Christophe Marine and Susan Schlenner and Gabriele Bergers",

year = "2023",

month = jan,

day = "9",

doi = "10.1016/j.ccell.2022.12.006",

language = "English",

volume = "41",

pages = "226--226",

journal = "Cancer Cell",

issn = "1535-6108",

publisher = "Cell Press",

number = "1",

}

Hua, Y, Vella, G, Rambow, F, Allen, E, Martinez, AA, Duhamel, M, Takeda, A, Jalkanen, S, Junius, S, Smeets, A, Nittner, D, Dimmeler, S, Hehlgans, T, Liston, A, Bosisio, FM, Floris, G, Laoui, D, Hollmén, M, Lambrechts, D, Merchiers, P, Marine, J-C, Schlenner, S & Bergers, G 2023, 'Correction: Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1+ T lymphocyte niches through a feed-forward loop', Cancer Cell, vol. 41, no. 1, pp. 226-226. https://doi.org/10.1016/j.ccell.2022.12.006

TY - JOUR

T1 - Correction: Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1+ T lymphocyte niches through a feed-forward loop

AU - Hua, Yichao

AU - Vella, Gerlanda

AU - Rambow, Florian

AU - Allen, Elizabeth

AU - Martinez, Asier Antoranz

AU - Duhamel, Marie

AU - Takeda, Akira

AU - Jalkanen, Sirpa

AU - Junius, Steffie

AU - Smeets, Ann

AU - Nittner, David

AU - Dimmeler, Stefanie

AU - Hehlgans, Thomas

AU - Liston, Adrian

AU - Bosisio, Francesca Maria

AU - Floris, Giuseppe

AU - Laoui, Damya

AU - Hollmén, Maija

AU - Lambrechts, Diether

AU - Merchiers, Pascal

AU - Marine, Jean-Christophe

AU - Schlenner, Susan

AU - Bergers, Gabriele

PY - 2023/1/9

Y1 - 2023/1/9

N2 - (Cancer Cell 40, 1600–1618; December 12, 2022) In this article, the authors demonstrated that antiangiogenic immunotherapies differentiate postcapillary venules into high-endothelial venules (HEVs) that foster permissive TCF1 + T lymphocyte niches. In the introduction, they mistakenly stated that HEVs express L-Selectin/CD62L, while HEVs express the sulphated and glycosylated ligands for L-Selectin/CD62L. The original article has been corrected online. The authors regret this error and apologize for any confusion this might have caused.

AB - (Cancer Cell 40, 1600–1618; December 12, 2022) In this article, the authors demonstrated that antiangiogenic immunotherapies differentiate postcapillary venules into high-endothelial venules (HEVs) that foster permissive TCF1 + T lymphocyte niches. In the introduction, they mistakenly stated that HEVs express L-Selectin/CD62L, while HEVs express the sulphated and glycosylated ligands for L-Selectin/CD62L. The original article has been corrected online. The authors regret this error and apologize for any confusion this might have caused.

UR - https://www.scopus.com/pages/publications/85144352117

U2 - 10.1016/j.ccell.2022.12.006

DO - 10.1016/j.ccell.2022.12.006

M3 - Article

C2 - 36626867

SN - 1535-6108

VL - 41

SP - 226

EP - 226

JO - Cancer Cell

JF - Cancer Cell

IS - 1

ER -

Correction: Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1+ T lymphocyte niches through a feed-forward loop

Abstract

Bibliographical note

Access to Document

Handle.net

Other files and links

Fingerprint

Cite this